Eli Lilly's plans for growth push stock to another new high — plus two more health stock updates
Eli Lilly's plans for growth push stock to another new high — plus two more health stock updates


Eli Lilly & Co. Mounjaro model tirzepatide remedy organized at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. 

George Frey | Bloomberg | Getty Images

Eli Lilly‘s presentation Tuesday night on the influential JPMorgan Healthcare Conference was gentle on near-term monetary updates, as anticipated, however heavy on dialogue in regards to the world’s most beneficial drugmaker’s plans to maintain its latest run of successes properly into the longer term. Investors favored what they heard and despatched Lilly shares to an all-time high Wednesday.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *